Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 found in travellers previously hospitalised in Gran Canaria, Spain
Thirteen patients with OXA-48-producing Klebsiella pneumoniae ST392 have been reported by Sweden and Norway between January and April 2018 - all returning travellers with prior hospital admission in Gran Canaria. Whole genome sequencing showed tight clustering between the bacterial isolates from the cases.
Rise of carbapenem-resistant Enterobactericaeae: A threat to health in Europe
Infections with bacteria resistant to carbapenems, a group of highly effective antibiotics, pose a significant threat to patients and healthcare systems in all EU/EEA countries, warns ECDC in a Rapid Risk Assessment.
Proper hand hygiene can prevent sepsis
In Europe, about 80 000 hospitalised patients are estimated to have at least one healthcare-associated infection on any given day. Proper cleaning of the hands, using antiseptic fluid, remains the single most effective way for hospital staff to prevent infections that can lead to sepsis.
Hospital professionals should strictly follow standard precautions to avoid rare, but possible hospital-acquired malaria
The occurrence of sporadic cases of hospital-acquired malaria in the EU is a reminder that such transmission is possible, although uncommon.
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Livestock-associated meticillin-resistant Staphylococcus aureus (LA-MRSA) among MRSA from humans across the EU/EEA, 2013: ECDC survey
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a ‘One Health’ issue. The ECDC advocates for periodic systematic surveys or integrated multi-sectorial surveillance to facilitate control measures.
Survey on antimicrobial resistance in intensive care units currently open
Antibiotic resistance is a threat to public health. It compromises the treatment of infected patients, in particular that of the most severely ill patients. Increasingly, intensive care physicians in Europe are confronted with infections caused by bacteria for which limited or no adequate treatment options are available.
ECDC tools: surveillance is essential to prevent and control healthcare-associated infections
Today, ECDC’s Healthcare-associated Infections Surveillance Network (HAI-Net) publishes two updated protocols for the surveillance of healthcare-associated infections (HAIs): one for surgical site infections (SSIs) and prevention indicators, and another one for HAIs and prevention indicators in intensive care units (ICUs), both to be used by European hospitals. An update of the protocol for the surveillance of Clostridium difficile infections (CDIs) was published on 21 April.
Point prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and long-term care facilities across Europe are ongoing
ECDC point prevalence surveys (PPSs) estimate that each year 3.5 million healthcare-associated infections occur in acute care hospitals, and 4.2 million in long-term care facilities (LTCFs) across Europe.
Healthcare-associated infections pose a major public health threat in long-term care facilities in Europe
An EU-wide survey estimated that 4.2 million healthcare-associated infections occur every year in European long-term care facilities, compared to an estimated 3.5 million occurring in European acute care hospitals, and that on any given day, over 116 400 residents have at least one active healthcare-associated infection. Pete Kinross, an expert in surveillance of healthcare-associated infections at the European Centre for Disease Prevention and Control (ECDC), speaks about these findings during a session on antimicrobial resistance in these healthcare settings, at ECCMID 2017.